OPCH - NASDAQ
Option Care Health, Inc.
$20.53
+1.2%Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
At a Glance
Live SnapshotOption Care Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
Option Care Health, Inc. Income Statement
OPCH • NASDAQ
| Option Care Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
5.6B | 5B | 4.3B | 3.9B | 3.4B | 3B | 2.3B | 1.9B | 817.2M | 935.6M | 982.2M | 922.7M | 696.5M | 593.4M | 554.5M | 430.7M | 1.3B | 1.4B | 1.2B | 1.2B | |
GROSS PROFIT | ||||||||||||||||||||
(4.6B) | (4B) | (3.3B) | (3.1B) | (2.7B) | (2.4B) | (1.8B) | (1.5B) | (547.9M) | (673.5M) | (722.3M) | (671.9M) | (489.8M) | (397.5M) | (339.1M) | (270.2M) | (1.2B) | (1.3B) | (1.1B) | (1B) | |
1B | 1B | 981.2M | 866.9M | 779.6M | 682.3M | 513M | 422.2M | 269.2M | 262.1M | 260M | 250.8M | 206.7M | 195.9M | 215.4M | 160.5M | 157.8M | 142.2M | 137M | 118.1M | |
OPERATING INCOME | ||||||||||||||||||||
(682.5M) | (691.2M) | (666.6M) | (626.7M) | (588.8M) | (571.5M) | (513.3M) | (383.9M) | (332.5M) | (298.3M) | (547.6M) | (250.8M) | (232.9M) | (182.6M) | (215.4M) | (153M) | (142.4M) | (58.7M) | (128.2M) | (101.8M) | |
(682.5M) | (630.3M) | (607.4M) | (566.1M) | (525.7M) | (500.2M) | (459.6M) | (345.9M) | (39.6M) | (38.8M) | (42.5M) | (49.3M) | (47.9M) | (162.9M) | (167.1M) | (133.4M) | (131.9M) | (125.2M) | (125.3M) | (127.7M) | |
337.9M | 321.8M | 314.6M | 240.2M | 190.8M | 110.8M | -319K | 38.3M | -63.3M | -36.2M | -287.6M | 11.9M | -26.3M | 13.3M | 44.9M | 7.5M | 15.5M | 83.5M | 8.9M | 16.2M | |
PRE-TAX INCOME | ||||||||||||||||||||
(63.2M) | (60.6M) | (62.2M) | (54.9M) | (55.5M) | (91.2M) | (73.4M) | (46.1M) | (52.1M) | (37.6M) | (37.3M) | (38.7M) | (28.2M) | (26.1M) | (28.3M) | (27.6M) | (1.9M) | (2.7M) | (3.3M) | (3M) | |
-63.2M | -60.6M | -62.2M | -54.9M | -55.5M | -91.2M | -73.4M | -46.1M | -52.1M | -37.6M | -37.3M | -38.7M | -28.2M | -26.1M | -28.3M | -27.6M | -1.9M | -2.7M | -3.3M | -3M | |
(0.0) | (60.9M) | (59.2M) | (60.6M) | (63.1M) | (71.3M) | (53.7M) | (38.1M) | (292.9M) | (259.5M) | (505.1M) | (201.4M) | (185M) | (19.7M) | (48.3M) | (19.6M) | (10.4M) | -66.5M | (2.9M) | -25.9M | |
-55M | -38.2M | 44.1M | -34.5M | -74.3M | -116M | -77.9M | -47M | -4.1M | 2M | -38.7M | -150.7M | -44.1M | -32.7M | -44.9M | -26.5M | -1.9M | -169.7M | -3.3M | -35.5M | |
282.9M | 283.6M | 358.7M | 205.8M | 116.5M | -5.2M | -78.2M | -8.8M | -67.4M | -34.2M | -326.4M | -138.7M | -70.4M | -19.4M | 11K | -19M | 13.5M | -86.2M | 5.6M | -19.3M | |
NET INCOME | ||||||||||||||||||||
(75.3M) | (71.8M) | (91.7M) | (55.2M) | -23.4M | (2.8M) | -2.3M | -2.7M | -4.1M | (2M) | -21.5M | (11.2M) | (1.3M) | -7.1M | (435K) | (48.7M) | -40.6M | -12.2M | (2.3M) | (19M) | |
207.6M | 211.8M | 267.1M | 150.6M | 139.9M | -8.1M | -75.9M | -6.1M | -64.2M | -42.8M | -300.1M | -147.5M | -69.7M | 64.7M | 7.9M | -69.1M | 54.1M | -74M | 3.3M | -38.3M |
SEC Filings
OPCH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 22, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 12, 2026 | May 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 02, 2026 | March 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 24, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 24, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 09, 2026 | 2026 |
Related Guides
Continue your OPCH research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.